Wendy Wisner is a journalist and international board certified lactation consultant (IBCLC). She has written about all things pregnancy, maternal/child health ...

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

HARP Doctoral Research Fellow and Haematology Registrar, Queen Mary University of London Stephen Hibbs receives funding from the Wellcome Trust through a HARP doctoral research fellowship. Kari ...

Augurex expands its 14-3-3eta test availability through a new partnership with Sonic Reference Laboratory, a division of Sonic Healthcare USA, to enhance the diagnosis and management of rheumatoid ...

An experimental depression drug that joined the Neurocrine Biosciences pipeline as part of a broader package from Takeda Pharmaceutical failed to meet the main goal of a mid-stage clinical trial. The ...

Since acquiring the 40-acre property, Sitex Group has been busy updating Zuckerberg’s Industrial Park in Saddle Brook to great success. Following a two-year, multimillion-dollar repositioning, the ...

BridgeBio has vaulted over the success bar it set for a phase 3 rare disease trial, linking the candidate to significant improvements on biomarker and clinical outcomes to tee up a filing for FDA ...

In order to successfully provide equitable access for all, the Adaptive Test Center (ATC) has certain procedures and rules to help facilitate a seamless and less stressful testing environment. We ...

NEW YORK – University of Washington spinout Monod Bio said Wednesday that it has been awarded a $750,000 grant from the Gates Foundation's Grand Challenges initiative to develop a diagnostic test for ...

Oxford BioDynamics, a U.K.-based maker of precision diagnostics, touted progress toward a first-of-its-kind blood test for chronic fatigue syndrome (CFS)—also known as myalgic ...